News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InVivo Therapeutics Corporation (NVIV) Announces Barrow Neurological Institute As Third Clinical Trial Site For Neuro-Spinal Scaffold


6/26/2014 8:53:34 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) announced today that a third clinical site, the Barrow Neurological Institute (BNI) in Phoenix, AZ, is now open for enrollment for patients with acute spinal cord injury (SCI). BNI at St. Joseph's Hospital and Medical Center is the largest dedicated neurosurgical center in the world and is a recognized leader in neurosurgical training, research, and patient care. More operative neurosurgical procedures take place at BNI than at any other institution in the United States. Nicholas Theodore, MD, Professor of Neurosurgery, Director of Neurosurgery Spine Program, and Director of Neurotrauma at BNI will be the study’s Principal Investigator.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES